Patients with high spinal cord injury may present with significant cardiac dysautonomia. There is a dearth of data regarding electromechanical interference to cardiac pacemakers from phrenic nerve stimulators which are used in such patients for respiratory support. We report an instance of bipolar lead permanent pacemaker insertion for ventricular standstill in a man with quadriplegia following C2 fracture and the measures we adopted to minimise electromagnetic interference with phrenic nerve stimulators. To the best of our knowledge, this is the first reported instance of successful pacemaker insertion in a quadriplegic patient on long-term diaphragmatic pacing.

Keywords:
Permanent pacemaker, Diaphragmatic pacing, Phrenic nerve stimulator, Electromagnetic interference
1.
Kolb C, Eicken A, Zrenner B, Schmitt C: Cardiac pacing in a patient with diaphragm pacing for congenital central hypoventilation syndrome (Ondine’s curse). J Cardiovasc Electrophysiol 2006;17:789–791.
2.
Movahed MR, Jalili M, Kiciman N: Absence of device-device interaction (DDI) in a patient with cardiac and diaphragmatic pacemakers for congenital central hypoventilation syndrome. Pacing Clin Electrophysiol 2005;28:1238–1239.
3.
Glenn WW, Phelps ML: Diaphragm pacing by electrical stimulation of the phrenic nerve. Neurosurgery 1985;17:974–984.
4.
Krassioukov A, Claydon VE: The clinical problems in cardiovascular control following spinal cord injury: an overview. Prog Brain Res 2006;152:223–229.
5.
Pinski SL, Trohman RG: Interference in implanted cardiac devices. Part I. Pacing Clin Electrophysiol 2002;25:1367–1381.
6.
Siu CW, Tse HF, Lau CP: Inappropriate implantable cardioverter defibrillator shock from a transcutaneous muscle stimulation device therapy. J Interv Card Electrophysiol 2005;13:73–75.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.